Furthermore, in the patients who developed liver inflammation after receiving a low dose (105 TCR+ T cells/kg) of HBV-TCR T cells, it is unlikely that the amount of cytolysis mediated by the small number of HBV-TCR T cells could sustain the abnormal serum ALT and total bilirubin levels observed for over 2 weeks (patient with mild liver inflammation) or ~80 days in the patient with a severe liver inflammation. Here, GPT is linked to Hepatitis.